Invention Grant
- Patent Title: Triazole compounds as T-type calcium channel blockers
-
Application No.: US15510980Application Date: 2015-09-14
-
Publication No.: US10246426B2Publication Date: 2019-04-02
- Inventor: Olivier Bezencon , John Gatfield , Bibia Heidmann , Romain Siegrist , Simon Stamm
- Applicant: IDORSIA PHARMACEUTICALS LTD
- Applicant Address: CH Allschwil
- Assignee: IDORSIA PHARMACEUTICALS LTD
- Current Assignee: IDORSIA PHARMACEUTICALS LTD
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Associates LLC
- Priority: WOPCT/EP2014/069592 20140915
- International Application: PCT/EP2015/070934 WO 20150914
- International Announcement: WO2016/041892 WO 20160324
- Main IPC: C07D249/04
- IPC: C07D249/04 ; C07D403/12 ; C07D401/12 ; C07D405/12 ; C07D401/10 ; C07D401/14 ; C07D403/06 ; C07D403/10 ; C07D405/06 ; C07D471/04
Abstract:
The invention relates to compounds of formula (I) wherein X, Y, R1, R2, (R4)n, and (R5)m are as defined in the description, and to pharmaceutically acceptable salts of such compounds. These compounds are useful as calcium T-channel blockers.
Public/Granted literature
- US20180230109A1 TRIAZOLE COMPOUNDS AS T-TYPE CALCIUM CHANNEL BLOCKERS Public/Granted day:2018-08-16
Information query
